Sponsor

Avance Clinical Pty Ltd.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Avance Clinical Pty Ltd. appears in 8 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials8
Recruiting shown2
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

8 shown
A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPDNCT07668518 · collaborator · 2026-08-05
RECRUITING
Study of S-4321 in Participants With an Autoimmune or Immune-mediated DiseaseNCT07455578 · collaborator · 2026-06-01
RECRUITING
Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide ImplantNCT07430059 · collaborator · 2026-07-01
NOT_YET_RECRUITING
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.NCT06975605 · collaborator · 2025-05-20
COMPLETED
Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy AdultsNCT06965881 · collaborator · 2025-05-08
TERMINATED
Assessment of Safety, Tolerability and Drug Levels of Exenatide ImplantNCT05670379 · collaborator · 2024-12-20
COMPLETED
Safety, PK and Efficacy of AI-061 in Advanced Solid TumorsNCT05858736 · collaborator · 2023-07-11
COMPLETED
A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly VolunteersNCT04983368 · collaborator · 2021-06-30
COMPLETED

Sponsor roles

collaborator8
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.